SBIR/STTR Research Award
Spectroscopic System for Therapeutic Drug Monitoring (THERASPEC)
Award amount
$999,988Program and phase
SBIR · Phase IIAward year
2015Award details
- Awarding agency
- Department of Defense
- Branch
- Defense Health Agency
- Recipient company
- CHROMOLOGIC LLC
- Proposal award date
- 2015-09-25
- Contract end date
- 2018-02-27
- UEI
- D9EVNTKKWLF3
- Solicitation number
- 2013.2
- Topic code
- A13-082
Research abstract
ChromoLogic LLC (CL) is developing a Spectroscopic System for Therapeutic Drug Monitoring (THERASPEC), to meet the Armys need for a compact, robust system to assess the peak and trough therapeutic drug concentrations in blood to provide real-time TDM in fixed and field medical facilities. The THERASPEC prototype is based on spectroscopic
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- Mitigation of Ionizing Irradiation-Induced Intestinal Damage by Second-Generation Probiotic LR-IFN-β
- Membrane-based AWE Device (MAWED)
- Ceramic membrane based portable oxygen generator (CEMPOG)
- CRISPR-based Assay for Portable Tropical Infection Diagnosis (CAPTIN-D)
- Wearable Heat Related Injury Risk Analysis (WHERA) system Resubmission
Research funding history
93 SBIR/STTR records share this UEI (2007–2025). Reported award amounts total $49,103,552. Reported amounts are not federal obligations.
Phases: Phase I, Phase II
Agencies: Department of Defense, Department of Health and Human Services, National Aeronautics and Space Administration, Department of Energy